What is HIVE's health score?

HIVE Digital Technologies Ltd. (HIVE) has a TradeApes health score of 60 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is HIVE's estimated fair value?

Based on our 5-year discounted cash flow model, HIVE Digital Technologies Ltd.'s estimated fair value is $3.7 per share, representing a -15.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is HIVE undervalued or overvalued?

Our model currently rates HIVE as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for HIVE... Refresh in a moment for the full analysis.

HIVE Digital Technologies Ltd. (HIVE)

Financials Fair Value low healthy

$4.37

Updated: 2026-06-05

TradeApes Score

Financial Strength

60 Healthy

Operating Trend

75 Strong

Relative Value

55 Mixed

Capital Allocation

30 Weak

Risk

80 Strong

Est. Fair Value $3.7

DCF Upside -15.3%

Sector Rank #1526 of 6447

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.